|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Bernat_Olle
|
|
gptkbp:collaboratedWith
|
gptkb:Janssen_Biotech
gptkb:Bristol_Myers_Squibb
|
|
gptkbp:developedBy
|
live biotherapeutic products
|
|
gptkbp:focusesOn
|
infectious diseases
immune-mediated diseases
microbiome therapeutics
|
|
gptkbp:foundedIn
|
2010
|
|
gptkbp:fundedBy
|
gptkb:PureTech_Health
gptkb:Invesco
gptkb:Bill_&_Melinda_Gates_Foundation
gptkb:Eli_Lilly_and_Company
gptkb:Colorcon_Ventures
gptkb:Health_for_Life_Capital
gptkb:JSR_Corporation
gptkb:Janssen_Biotech
gptkb:Leaps_by_Bayer
gptkb:Mizuho_Securities
gptkb:Rock_Springs_Capital
gptkb:Seventure_Partners
gptkb:Shumway_Capital
gptkb:SymBiosis
gptkb:Fidelity_Management_&_Research_Company
gptkb:Bristol_Myers_Squibb
|
|
gptkbp:headquartersLocation
|
gptkb:Cambridge,_Massachusetts
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:parentCompany
|
gptkb:PureTech_Health
|
|
gptkbp:productPipelineIncludes
|
gptkb:VE202
gptkb:VE303
gptkb:VE416
gptkb:VE800
|
|
gptkbp:specializesIn
|
rationally-defined bacterial consortia
|
|
gptkbp:website
|
https://www.vedantabio.com/
|
|
gptkbp:bfsParent
|
gptkb:PureTech_Health
|
|
gptkbp:bfsLayer
|
4
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Vedanta Biosciences
|